The FDA approved a controversial, $56,000-a-year Alzheimer’s drug despite opposition inside the agency, internal memos show Allison DeAngelis 22 jun 2021
INSIDE BIOTECH: See the drug companies that are growing the fastest and pay workers the most Allison DeAngelis 18 mei 2021
Premium Waarom het vrijgeven van patenten voor coronavaccins niet gaat helpen om de productie te versnellen Allison DeAngelis, Business Insider Nederland 08 mei 2021
Premium Megabiotechs: de nieuwe trend van snelle, meervoudige fusies van kleinere spelers creëert de nodige risico’s Allison DeAngelis 06 mei 2021
Coronavirus variants called ‘escape mutants’ threaten our progress in the pandemic Allison DeAngelis 04 mei 2021
See the pitch deck for a new startup focused on preventing disease outbreaks Allison DeAngelis 29 apr 2021
New data shows Moderna’s vaccine remains highly protective 6 months after shots Allison DeAngelis 13 apr 2021
